63% of the patients in those studies had life expectancies of one year, 46% had life expectancies of three years, and 22% had life expectancies of five years. For patients who underwent OLTS for hepatitis C, 79% had life expectancies of one year, 79% had life expectancies of three years, and 66% had life expectancies of five years. - The rate of relapse was 52%.
Es llamativo que en 16 explantes no se encontró tumor viable y 7 de estos pacientes no tenían diagnóstico histológico previo de tumor, lo que sugiere la posibilidad de un diagnóstico incorrecto previo.